Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities (Tables)

Note 8 - Accrued Liabilities (Tables)

6 Months Ended

Jun. 30, 2023

Notes Tables

Schedule of Accrued Liabilities [Table Text Block]

		*June 30, 2023*				*December 31, 2022*
Salaries, benefits and related expenses		$	1,799			$	1,843
Device warranty			338				274
Other			256				161
Total		$	2,393			$	2,278

Product Maintenance And Warranty [Table Text Block]

		*Three Months Ended*				*Six Months Ended*
		*June 30, 2023*				*June 30, 2023*
Balance at beginning of period		$	426			$	413
Additions for estimated future costs			123				236
Incurred costs			(107	)			(207	)
Balance at end of period		$	442			$	442

		*Balance as of June 30, 2023*
Current portion		$	338
Long-term portion			104
Total		$	442